PropertyValue
?:abstract
  • We argue that the COVID-19 pandemic will result in increased antimicrobial resistance (AMR) Broad-spectrum antibiotic use is common among hospitalized COVID-19 patients and in excess of reported secondary infection rates, suggesting unnecessary prescribing Selection pressure is likely to be particularly intense in COVID-19 epicentres and within non-epicentre hospital units dedicated to COVID-19 care Risk factors that increase the likelihood of hospitalization or poor outcomes among COVID-19 patients, such as advanced age, nursing home residence, debilitation, diabetes and cardiopulmonary or other underlying systemic diseases, also predispose to AMR infections Worry for AMR emergence is heightened since first-wave COVID-19 epicentres were also AMR epicentres Disruptive direct and indirect effects of COVID-19 globally on economic systems, governance and public health expenditure and infrastructure may fuel AMR spread We anticipate that the impact of COVID-19 on AMR will vary between epicentres and non-epicentres, by geographic region, hospital to hospital within regions and within specific hospital units
is ?:annotates of
?:creator
?:journal
  • JAC-Antimicrobial_Resistance
?:license
  • unk
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:source
  • WHO
?:title
  • PRO: The COVID-19 pandemic will result in increased antimicrobial resistance rates
?:type
?:who_covidence_id
  • #957726
?:year
  • 2020

Metadata

Anon_0  
expand all